Cricket Health Secures $24M Series A Funding to Expand Tech-Enabled Remote Care Model for Kidney Disease Patients

VCBeat (WeChat: vcbeat)According to PR Newswire, Cricket Health, a technology-enabled comprehensive kidney care provider, announced today that it has completed a $24 million Series A financing round. The round was led by new investor Oak HC/FT, with participation from other new investors including Cigna Corporation, LifeForce Capital, iSeed Ventures, and Liquid 2 Ventures (founded by Joe Montana), among several other institutional and individual investors.

Cricket Health’s Funding History (Source: Crunchbase)

Following the completion of its Series A financing, Cricket Health will use the funds to expand its technology-enabled support programs and clinical footprint, including the ongoing development of care management solutions for patients with end-stage renal disease (ESRD) to delay the need for dialysis, as well as the creation of new home dialysis and in-center programs.

Cricket Health was founded in 2015,Headquartered in San Francisco, California.ThisProvide technical support for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), offering cost-effective, comprehensive kidney care and dialysis treatment to help them maintain their health at home and outside the hospital.

The company's core team includes:

Arvind Rajan: Veteran of the technology industry and former LinkedIn executive;

Vince Kim: Former Partner at Aberdare Ventures, an early-stage healthcare technology venture capital firm;

James Chaukos: Previously held a business operations role at LinkedIn.

Last year, the company recruited renowned nephrologist and medical professor Carmen A. Peralta from the University of California, San Francisco, as well as Danny Shapiro, a veteran in the kidney care industry who previously served as Chief Business Officer at DaVita, the Fortune 500 dialysis services giant.

In the United States, the prevalence of end-stage renal disease (ESRD) is rising, with annual expenditures exceeding billions of dollars, imposing a significant economic and public health burden. Prior to reaching ESRD, patients are often unaware of their various treatment options, including transplantation and home dialysis. Although in-center hemodialysis is the most common form of renal replacement therapy (RRT) in the United States, many patients lack comprehensive and timely education to make informed treatment choices. This gap may prevent them from pursuing home dialysis therapies or undergoing evaluation for kidney transplantation. However, the rise of telemedicine offers new opportunities to improve this situation.

Cricket Health’s treatment plans prioritize slowing the progression of kidney failure, keeping patients out of the hospital, ensuring readiness for care transitions, and supporting patients through any form of end-stage renal disease (ESRD) therapy. This is achieved through a comprehensive suite of services: nephrology practices offering telehealth, in-person, and home-based care; a multidisciplinary care team that coordinates care and manages outcomes; state-of-the-art technology providing patient education along with 24/7 companionship and clinical support; and dialysis care delivered either at home or in redesigned centers, empowering patients with autonomous choice.

Cricket Health provides patients with remote, in-person, and home-based care. Its multidisciplinary care teams collaborate with patients to reinforce and extend the work of nephrologists, while delivering remote monitoring of vital signs, patient education, and patient-centered care.

Meanwhile, high-risk patients are accurately identified before the onset of kidney failure, and their renal function is preserved through remote guidance by specialists. This approach enables patients to remain out of the hospital and ensures an optimal transition to end-stage renal disease (ESRD). Cricket Health provides support for all potential care pathways, including transplantation, conservative management, and home-based or authorized center-based dialysis.